DGKA
Diacylglycerol kinase alpha
Also known as: DAGK, DAGK1, DGK-alpha, DGKA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P23743
- Gene
- DGKA
- Ensembl
- ENSG00000065357
- Chromosome
- 12
- Canonical length
- 735 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Mitochondria
OverviewNCBI Gene
The protein encoded by this gene belongs to the eukaryotic diacylglycerol kinase family. It acts as a modulator that competes with protein kinase C for the second messenger diacylglycerol in intracellular signaling pathways. It also plays an important role in the resynthesis of phosphatidylinositols and phosphorylating diacylglycerol to phosphatidic acid. Several transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Apr 2017]
Canonical amino-acid sequenceUniProt
735 residues, UniProt reviewed canonical sequence.
>P23743|DGKA
1 MAKERGLISP SDFAQLQKYM EYSTKKVSDV LKLFEDGEMA KYVQGDAIGY EGFQQFLKIY
61 LEVDNVPRHL SLALFQSFET GHCLNETNVT KDVVCLNDVS CYFSLLEGGR PEDKLEFTFK
121 LYDTDRNGIL DSSEVDKIIL QMMRVAEYLD WDVSELRPIL QEMMKEIDYD GSGSVSQAEW
181 VRAGATTVPL LVLLGLEMTL KDDGQHMWRP KRFPRPVYCN LCESSIGLGK QGLSCNLCKY
241 TVHDQCAMKA LPCEVSTYAK SRKDIGVQSH VWVRGGCESG RCDRCQKKIR IYHSLTGLHC
301 VWCHLEIHDD CLQAVGHECD CGLLRDHILP PSSIYPSVLA SGPDRKNSKT SQKTMDDLNL
361 STSEALRIDP VPNTHPLLVF VNPKSGGKQG QRVLWKFQYI LNPRQVFNLL KDGPEIGLRL
421 FKDVPDSRIL VCGGDGTVGW ILETIDKANL PVLPPVAVLP LGTGNDLARC LRWGGGYEGQ
481 NLAKILKDLE MSKVVHMDRW SVEVIPQQTE EKSDPVPFQI INNYFSIGVD ASIAHRFHIM
541 REKYPEKFNS RMKNKLWYFE FATSESIFST CKKLEESLTV EICGKPLDLS NLSLEGIAVL
601 NIPSMHGGSN LWGDTRRPHG DIYGINQALG ATAKVITDPD ILKTCVPDLS DKRLEVVGLE
661 GAIEMGQIYT KLKNAGRRLA KCSEITFHTT KTLPMQIDGE PWMQTPCTIK ITHKNQMPML
721 MGPPPRSTNF FGFLSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DGKA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 185 nTPM
Expression across tissuesHPA
Tissue
- thymus: 185 nTPM
- tonsil: 95 nTPM
- esophagus: 92 nTPM
- lymph node: 89 nTPM
- skin: 80 nTPM
- small intestine: 67 nTPM
Single-cell type
- esophageal apical cells: 200 nCPM
- enterocytes: 97 nCPM
- ocular epithelial cells: 88 nCPM
- prostatic hillock cells: 85 nCPM
- thymocytes: 75 nCPM
- t-cells: 69 nCPM
Immune cell
- naive CD4 T-cell: 87 nTPM
- T-reg: 87 nTPM
- memory CD4 T-cell: 71 nTPM
- naive CD8 T-cell: 52 nTPM
- total PBMC: 36 nTPM
- MAIT T-cell: 36 nTPM
Brain region
- basal ganglia: 19 nTPM
- cerebral cortex: 16 nTPM
- amygdala: 14 nTPM
- choroid plexus: 13 nTPM
- hippocampal formation: 13 nTPM
- cerebellum: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.46
- gnomAD missense Z
- 2.5
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- diacylglycerol metabolic process
- glycerolipid metabolic process
- intracellular signal transduction
- lipid phosphorylation
- phosphatidic acid biosynthetic process
- phospholipase C-activating G protein-coupled receptor signaling pathway
- platelet activation
Molecular functions
- alkylglycerol kinase activity
- ATP binding
- ATP-dependent diacylglycerol kinase activity
- calcium ion binding
- kinase activity
- lipid binding
- phospholipid binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Diacylglycerol kinase, accessory domain
- Diacylglycerol kinase, catalytic domain
- EF-hand domain
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- EF-hand domain pair
- NAD kinase/diacylglycerol kinase-like domain superfamily
- Inorganic polyphosphate/ATP-NAD kinase, N-terminal
- EF-Hand 1, calcium-binding site
- Diacylglycerol kinase type I, N-terminal
- Diacylglycerol kinase
- DGK type I, N-terminal domain superfamily
- C1-like domain superfamily
- Phorbol esters/diacylglycerol binding domain (C1 domain)
- Diacylglycerol kinase accessory domain
- Diacylglycerol kinase catalytic domain
- Diacylglycerol kinase N-terminus
- Diacylglycerol kinase alpha, second protein kinase C conserved region 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DGKA as an antibody target. Whether an autoantibody or antibody against DGKA could matter depends on whether native DGKA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DGKA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DGKA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...